Alexandra Balcom is CFO at Nuvalent, Inc. (NUVL). They have made 2 open-market trades across 1 company since 2023, most recently 2026-07-15.
CIK 0001862147
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NUVL | 14,350 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-07-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUVL | SELL · 10b5-1 | 2026-07-01 | 2026-07-06 | $123.58 | $1.4M | N/A | N/A | N/A |
| NUVL | SELL · 10b5-1 | 2026-06-01 | 2026-06-03 | $98.69 | $1.1M | +34.2% | +34.6% | N/A |
| NUVL | SELL · 10b5-1 | 2026-05-01 | 2026-05-05 | $99.00 | $1.1M | +1.4% | -6.8% | N/A |
| NUVL | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $105.21 | $1.2M | +0.5% | -1.7% | +18.7% |
| NUVL | SELL · 10b5-1 | 2026-03-24 | 2026-03-26 | $98.15 | $2.5M | +7.2% | +6.2% | +26.1% |
| NUVL | SELL | 2026-01-05 | 2026-01-07 | $97.25 | $721K | -0.1% | -2.3% | -3.6% |
| NUVL | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $110.32 | $1.6M | +0.2% | -0.4% | -3.1% |
| NUVL | SELL · 10b5-1 | 2025-11-17 | 2025-11-19 | $99.56 | $4.1M | -2.0% | -3.1% | -4.6% |
| NUVL | SELL · 10b5-1 | 2025-10-15 | 2025-10-17 | $85.57 | $288K | +10.6% | +16.0% | +14.1% |
| NUVL | SELL · 10b5-1 | 2025-10-13 | 2025-10-15 | $87.64 | $5.8M | +8.6% | +7.2% | +12.4% |
| NUVL | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $85.48 | $3.4M | +6.1% | +10.1% | +19.3% |
| NUVL | SELL · 10b5-1 | 2025-09-29 | 2025-10-01 | $85.04 | $3.0M | +8.7% | +20.3% | +21.6% |
| NUVL | SELL · 10b5-1 | 2025-07-15 | 2025-07-17 | $84.43 | $2.1M | -8.4% | -13.3% | +3.6% |
| NUVL | SELL · 10b5-1 | 2025-06-27 | 2025-07-01 | $80.02 | $1.6M | +9.2% | +1.1% | +9.5% |
| NUVL | SELL · 10b5-1 | 2025-01-06 | 2025-01-08 | $79.68 | $640K | +5.9% | +11.6% | -22.7% |
| NUVL | SELL · 10b5-1 | 2024-11-29 | 2024-12-03 | $95.79 | $1.9M | -8.2% | -15.5% | -25.0% |
| NUVL | SELL · 10b5-1 | 2024-10-31 | 2024-11-04 | $89.18 | $1.5M | +1.7% | +6.2% | -4.3% |
| NUVL | SELL · 10b5-1 | 2024-09-30 | 2024-10-02 | $101.14 | $2.0M | +1.3% | -12.5% | -23.2% |
| NUVL | SELL · 10b5-1 | 2024-08-30 | 2024-09-04 | $84.21 | $1.7M | +32.5% | +24.0% | +12.0% |
| NUVL | SELL · 10b5-1 | 2024-07-31 | 2024-08-02 | $79.55 | $1.5M | +7.5% | +28.5% | +35.9% |
| NUVL | SELL · 10b5-1 | 2024-06-28 | 2024-07-02 | $75.40 | $1.5M | +12.1% | +4.9% | +40.8% |
| NUVL | SELL | 2023-12-18 | 2023-12-20 | $75.82 | $2.3M | +2.7% | +5.4% | +9.1% |
| NUVL | SELL · 10b5-1 | 2023-07-31 | 2023-08-01 | $48.99 | $2.4M | -10.8% | -5.5% | +4.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.